|Phone||+1 345 946 5556|
|Description||Venture capital firm|
NanoDimension is a venture capital firm supporting top entrepreneurial teams to build nanotech companies with the potential to become world leaders in their field.
NanoDimension provides equity financing and management assistance to early stage start-ups as well as later-stage commercially oriented organizations. NanoDimension is committed to earn long-term capital gains for its investors by aligning the interests of all stakeholders. To achieve this objective, NanoDimension relies on its proprietary investment strategy and its unique expertise, which ensure superior deal generation, investment assessment and investment management in the field of Nanotechnology.
|Blend Therapeutics||12/2013||Series B||$21M||3|
|View Inc.||11/2013||Private Equity||$12.6M||3|
|Crocus Technology||7/2013||Series D||€34M||5|
|View Inc.||6/2012||Series D||$55M||6|
|View Inc.||12/2010||Series C||$30M||5|
|BIND Therapeutics||6/2010||Series C||$12.4M||4|
|Selecta Biosciences||4/2010||Series C||$15M||5|
|SBA Materials||1/2010||Venture Round||$5.16M||1|
|Selecta Biosciences||2/2009||Series B||$15.1M||4|
|Crocus Technology||10/2008||Series B||€11.5M||6|